{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:28:43Z","timestamp":1778048923709,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.4158\/ep.14.2.201","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T22:07:48Z","timestamp":1365199668000},"page":"201-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Invasive Breast Cancer After Initiation of Testosterone Replacement Therapy in A Man\u2014A Warning To Endocrinologists"],"prefix":"10.1016","volume":"14","author":[{"given":"Sunil Raj","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moushmi","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.14.2.201_bb0005","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"Gerontol A Biol Sci Med Sci."},{"key":"10.4158\/EP.14.2.201_bb0010","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.2000.18.4.847","article-title":"Hormonal predictors of prostate cancer: a meta-analysis","volume":"18","author":"Shaneyfelt","year":"2000","journal-title":"J Clin Oncol."},{"key":"10.4158\/EP.14.2.201_bb0015","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2005-2847","article-title":"Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline [published correction appears in J Clin Endocrinol Metab. 2006;91:2688]","volume":"91","author":"Bhasin","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.2.201_bb0020","first-page":"475","article-title":"54-year old man with breast cancer after prolonged testosterone therapy [with discussion]","volume":"3","author":"Sorscher","year":"2005","journal-title":"Clin Adv Hematol Oncol."},{"key":"10.4158\/EP.14.2.201_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-005-9074-y","article-title":"Breast cancer and long-term hormonal treatment of male hypogonadism [published correction appears in Breast Cancer Res Treat. 2007;102:251]","volume":"96","author":"Medras","year":"2006","journal-title":"Breast Cancer Res Treat."},{"key":"10.4158\/EP.14.2.201_bb0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.20.14.1","article-title":"Epidemiology of male breast cancer","volume":"14","author":"Weiss","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.4158\/EP.14.2.201_bb0035","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/0003-4819-137-8-200210150-00013","article-title":"Breast cancer in men","volume":"137","author":"Giordano","year":"2002","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.14.2.201_bb0040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(06)68226-3","article-title":"Male breast cancer [published correction appears in Lancet. 2006;367: 1818]","volume":"367","author":"Fentiman","year":"2006","journal-title":"Lancet."},{"key":"10.4158\/EP.14.2.201_bb0045","first-page":"352","article-title":"Male breast cancer. 3. Breast cancer in association with the Klinefelter syndrome","volume":"81","author":"Scheike","year":"1973","journal-title":"Acta Pathol Microbiol Scand [A]."},{"key":"10.4158\/EP.14.2.201_bb0050","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/jmg.8.4.460","article-title":"Carcinoma of the breast and Klinefelter\u2019s syndrome","volume":"8","author":"Harnden","year":"1971","journal-title":"J Med Genet."},{"key":"10.4158\/EP.14.2.201_bb0055","first-page":"4293","article-title":"Prevalence of Klinefelter\u2019s syndrome in male breast cancer patients","volume":"17","author":"Hultborn","year":"1997","journal-title":"Anticancer Res."},{"key":"10.4158\/EP.14.2.201_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jama.1951.03670010011002","article-title":"Bilateral carcinoma of male breast after estrogen therapy","volume":"146","author":"McClure","year":"1951","journal-title":"JAMA."},{"key":"10.4158\/EP.14.2.201_bb0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.2.5597.83","article-title":"Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics","volume":"2","author":"Symmers","year":"1968","journal-title":"Br Med J."},{"key":"10.4158\/EP.14.2.201_bb0070","first-page":"269","article-title":"Risk factors for male breast cancer (United States)","volume":"9","author":"Hsing","year":"1998","journal-title":"Cancer Causes Control."},{"key":"10.4158\/EP.14.2.201_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-0760(03)00390-X","article-title":"Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells","volume":"87","author":"Russo","year":"2003","journal-title":"J Steroid Biochem Mol Biol."},{"key":"10.4158\/EP.14.2.201_bb0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1210\/er.2004-0015","article-title":"Aromatase inhibitors in the treatment of breast cancer","volume":"26","author":"Brueggemeier","year":"2005","journal-title":"Endocr Rev."},{"key":"10.4158\/EP.14.2.201_bb0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/028418601750288181","article-title":"Risk factors for male breast cancer\u2014a case-control study from Scandinavia","volume":"40","author":"Ewertz","year":"2001","journal-title":"Acta Oncol."},{"key":"10.4158\/EP.14.2.201_bb0090","first-page":"1326","article-title":"A case-control study of male breast cancer","volume":"48","author":"Casagrande","year":"1988","journal-title":"Cancer Res."},{"key":"10.4158\/EP.14.2.201_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archinte.1983.00350020055012","article-title":"Hormonal therapy for metastatic male breast cancer","volume":"143","author":"Kantarjian","year":"1983","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.14.2.201_bb0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jso.20233","article-title":"Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer","volume":"90","author":"Zabolotny","year":"2005","journal-title":"J Surg Oncol."},{"key":"10.4158\/EP.14.2.201_bb0105","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0015-0282(16)43160-2","article-title":"Hormonal effects of an anti-estrogen, tamoxifen, in normal and oligospermic men","volume":"29","author":"Vermeulen","year":"1978","journal-title":"Fertil Steril."},{"key":"10.4158\/EP.14.2.201_bb0110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1439-0272.1984.tb00414.x","article-title":"Estrogens in feedback regulation of gonadotropin secretion in men: effects of administration of estrogen to agonadal subjects and the antiestrogen tamoxifen and the aromatase inhibitor delta1-testolactone to eugonadal subjects","volume":"16","author":"Gooren","year":"1984","journal-title":"Andrologia."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20428812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20428812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/51141M2H72G61166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:47:55Z","timestamp":1761515275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20428812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1530891X20428812"],"URL":"https:\/\/doi.org\/10.4158\/ep.14.2.201","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive Breast Cancer After Initiation of Testosterone Replacement Therapy in A Man\u2014A Warning To Endocrinologists","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.14.2.201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}